SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-074895
Filing Date
2020-03-16
Accepted
2020-03-16 16:19:02
Documents
7
Effectiveness Date
2020-03-16

Document Format Files

Seq Description Document Type Size
1 DEFA14A d831320ddefa14a.htm DEFA14A 43543
2 GRAPHIC g831320page2.jpg GRAPHIC 1494
3 GRAPHIC g831320page2a.jpg GRAPHIC 2162
4 GRAPHIC g831320page3.jpg GRAPHIC 1468
5 GRAPHIC g831320page3a.jpg GRAPHIC 2870
6 GRAPHIC g831320page4.jpg GRAPHIC 1444
7 GRAPHIC g831320page5.jpg GRAPHIC 1473
  Complete submission text file 0001193125-20-074895.txt   60789
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14956 | Film No.: 20717371
SIC: 2834 Pharmaceutical Preparations